{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["43(1)"],"submitter":["Bajpai P"],"journal":["Journal of experimental & clinical cancer research : CR"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11238352"],"repository":["biostudies-literature"],"pubmed_title":["Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer"],"pmcid":["PMC11238352"],"pubmed_authors":["Manne U","Chandrashekar D","Kim H","Agarwal S","Paluri R","Afaq F","Al Diffalha S","Manne A","Khushman M","Shelton A","Miller C","Singh R","Nagaraju G","Singh S","Bajpai P","Varambally S"],"additional_accession":[]},"is_claimable":false,"name":"Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer","description":null,"dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jan","modification":"2025-04-05T15:48:13.788Z","creation":"2025-04-05T15:48:13.788Z"},"accession":"S-EPMC11238352","cross_references":{}}